Back
Alarum Technologies Ltd. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
34
ALAR
Alarum Technologies Ltd.
Last Price:
$7.95
Seasonality Move:
5.17%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$105.07
Seasonality Move:
-6.7%
Sell
34
Alarum Technologies Ltd. (ALAR)
is a Sell
Is Alarum Technologies Ltd. a Buy, Sell or Hold?
-
The current Alarum Technologies Ltd. [ALAR] share price is $8.16. The Score for ALAR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
ALAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.60. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALAR Stock Price Chart
What is Alarum Technologies Ltd.'s stock price today?
-
The Alarum Technologies Ltd. share price today is $8.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALAR is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
ALAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 18.3 | Sell |
| Chaikin Money Flow: | -34772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.63 - 14.87) | Sell |
| Bollinger Bands (100): | (12.01 - 16.23) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | -195325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.6 - 107.92) | Buy |
| Bollinger Bands (100): | (92.83 - 106.97) | Buy |
ALAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.12 | Sell |
| 20-day SMA: | 11.41 | Sell |
| 50-day SMA: | 13.56 | Sell |
| 200-day SMA: | 11.31 | Sell |
| 8-day EMA: | 9.18 | Sell |
| 20-day EMA: | 10.91 | Sell |
| 50-day EMA: | 12.73 | Sell |
| 200-day EMA: | 12.86 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.83 | Sell |
| 20-day SMA: | 102.55 | Buy |
| 50-day SMA: | 104.26 | Buy |
| 200-day SMA: | 80.37 | Buy |
| 8-day EMA: | 104.76 | Sell |
| 20-day EMA: | 104.28 | Buy |
| 50-day EMA: | 102.89 | Buy |
| 200-day EMA: | 85.54 | Buy |
Alarum Technologies Ltd. Earnings Growth & ALAR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.05 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Alarum Technologies Ltd. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||